Author:
Pinto Patricia,Shelar Tejashree,Nawadkar Vidhya,Mirgal Darshana,Mukaddam Alfiya,Nair Preethi,Kasatkar Priyanka,Gaikwad Tejasvita,Ali Shahnaz,Jadli Anshul,Patil Rucha,Parihar Anita,Shanbhag Sharda,Kulkarni Bipin,Ghosh Kanjaksha,Shetty Shrimati
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Shirahata A, Fukutake K, Higasa S, Mimaya J, Oka T, Shima M et al Study Group on Factors involved in Formation of Inhibitors to Factor VIII and IX Preparations (2011) An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan. Haemophilia 17:771–776
2. Carpenter SL, Michael Soucie J, Sterner S, Presley R, Treatment Center Network (HTCN) Investigators (2012) Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the universal data collection database. Haemophilia 18:e260–e265
3. Webert KE, Rivard GE, Teitel J, Carcao M, Lillicrap D, St-Louis J, Walker IR (2012) Low prevalence of inhibitor antibodies in the Canadian haemophilia population. Haemophilia 18:e254–e259
4. Au WY, Lee V, Kho B, Ling AS, Chan D, Chan EY et al (2011) A synopsis of current haemophilia care in Hong Kong. Hong Kong Med J 17:189–194
5. Wang XF, Zhao YQ, Yang RC, Wu JS, Sun J, Zhang XS et al (2010) The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A. Haemophilia 16:632–639
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献